Press releases

Die Zahl der Deutschen, die unter Schlafproblemen leiden, nimmt stetig zu. Nur eine einzige unruhige Nacht kann die Motivation, die...

Read more

In der Tübinger Neurologischen Universitätsklinik und dem Hertie-Institut für klinische Hirnforschung startet eine klinische Studie, die ein neues...

Read more

Prof. Thomas Gasser, chairman of the board of directors and director of the Department for Neurodegenerative Diseases at the HIH, has been awarded the...

Read more

Tübingen researchers led by Professor Dr. Markus Siegel can read out the content and form of a speech sound from brain signals several seconds before...

Read more

Dr. Simone Mayer and parents' initiative receive the award endowed with 50,000 euro

Read more

Tübingen researchers describe connection between action and feeling of authorship - finding sheds light on delusions of external control in...

Read more

Tübingen researchers develop a three-dimensional brain tissue model to study environmental influences on embyronal brain development in the Petri dish

Read more

For the first time in Europe, Tübingen physicians make use of an RNA therapy specifically tailored to one patient

Read more

A pioneering collaborative project between a Baden-Württemberg research team and patient association receive two million U.S. dollars

Read more

Protein plaques in the brain are the cause of Alzheimer's disease and the starting point for possible therapies. At later stages, however, the disease...

Read more
Press contact
Press contactProvisional Director of Communications
Silke DutzPhone 07071 29 88802silke.dutz@medizin.uni-tuebingen.deAddress

Hertie Institute for Clinical Brain Research
Director of Communications

Otfried-Müller-Str. 27
72076 Tübingen